Delaware Mesothelioma Fact Sheet
While mesothelioma is a problem in all states, the specific incident rate for Delaware is 1.5 / 100,000. This is above the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in DE, recent DE mesothelioma-related court cases, mesothelioma specialists in DE and potential asbestos hotspots in Delaware.
Delaware Mesothelioma Info
By clicking on the above tabs, you will find information on mesothelioma specific to the state of Delaware
Delaware Research and Clinical Trials
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Delaware Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Delaware Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Delaware Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Delaware Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
GMC v. Grenier
Nos. 453, 2007 And 578, 2007 (Consolidated), SUPREME COURT OF DELAWARE, June 15, 2009, Submitted, August 24, 2009, Decided
Nos. 453, 2007 And 578, 2007 (Consolidated), SUPREME COURT OF DELAWARE, June 15, 2009, Submitted, August 24, 2009, Decided
Riedel v. ICI Ams. Inc.
No. 156, 2008, SUPREME COURT OF DELAWARE, December 10, 2008, Submitted, March 4, 2009, Decided
No. 156, 2008, SUPREME COURT OF DELAWARE, December 10, 2008, Submitted, March 4, 2009, Decided
GMC v. Grenier
No. 453, 2007 & 578, 2007, SUPREME COURT OF DELAWARE, October 29, 2008, Submitted, February 4, 2009, Decided
No. 453, 2007 & 578, 2007, SUPREME COURT OF DELAWARE, October 29, 2008, Submitted, February 4, 2009, Decided
Roca v. E.I. du Pont de Nemours & Co.
No. 640, 2002 , SUPREME COURT OF DELAWARE, November 4, 2003, Submitted , January 30, 2004, Decided
No. 640, 2002 , SUPREME COURT OF DELAWARE, November 4, 2003, Submitted , January 30, 2004, Decided
Viking Pump, Inc. v. Century Indem. Co.
C.A. No. 1465-VCS, COURT OF CHANCERY OF DELAWARE, NEW CASTLE, August 7, 2009, Submitted, October 14, 2009, Decided
C.A. No. 1465-VCS, COURT OF CHANCERY OF DELAWARE, NEW CASTLE, August 7, 2009, Submitted, October 14, 2009, Decided
Scaife v. Astrazeneca LP
C.A. NO. 06C-04-218 SER, SUPERIOR COURT OF DELAWARE, NEW CASTLE, March 27, 2009, Submitted, June 9, 2009, Decided
C.A. NO. 06C-04-218 SER, SUPERIOR COURT OF DELAWARE, NEW CASTLE, March 27, 2009, Submitted, June 9, 2009, Decided
Grenier v. GMC (In re Asbestos Litig.)
C.A. No. 05C-11-257 ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, February 4, 2009, Decided
C.A. No. 05C-11-257 ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, February 4, 2009, Decided
Lagrone v. American Mortell Corp.
C.A. No. 04C-10-116-ASB, C.A. No. 07C-12-019-JRS, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 20, 2008, Submitted, September 4, 2008, Decided
C.A. No. 04C-10-116-ASB, C.A. No. 07C-12-019-JRS, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 20, 2008, Submitted, September 4, 2008, Decided
In re Asbestos Litig.
C.A. NO. 04C-07-099-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 26, 2007, Submitted, December 21, 2007, Decided
C.A. NO. 04C-07-099-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, June 26, 2007, Submitted, December 21, 2007, Decided
Lagrone v. AADG, Inc. (In re Asbestos Litig.)
C.A. No. 04C-10-116-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, July 9, 2007, Submitted, August 27, 2007, Decided
C.A. No. 04C-10-116-ASB, SUPERIOR COURT OF DELAWARE, NEW CASTLE, July 9, 2007, Submitted, August 27, 2007, Decided
Hospitals and Cancer Centers
We do not have any doctors or cancer centers for this state at the moment.
We do not have any doctors or cancer centers for this state at the moment.
| City | Site |
| Delaware City |
Getty Oil Refinery |
| Wilmington |
American Oil Beatty Construction Charles Beatty Drywall Daniels Construction Delaware Power Light Delaware Steel Fabricating Dry Waller Local Union 100 General Electric Presidential Towers W.R. Grace |
Research
Clinical Trials
Condition: Malignant Mesothelioma
Intervention: Drug: carboplatin; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium
More Information
Intervention: Drug: carboplatin; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium
More Information
Active, not recruiting Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
More Information
Intervention: Drug: dasatinib; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
More Information
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: MORAb-009 by IV on Days 1 and 8 every 21 days for 6 cycles.
More Information
Intervention: Drug: MORAb-009 by IV on Days 1 and 8 every 21 days for 6 cycles.
More Information
